SCHEMBL13626930

SCHEMBL13626930

Bc1ccc(-c2cc(OC)cc(OC)c2)c2nc(O)cnc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 5/20 0.42
ABCB1 P08183 5/20 0.42
BCR P11274 5/20 0.42
FGFR1 P11362 2/20 0.39
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
MAPT P10636 2/20 0.37
TP53 P04637 1/20 0.37
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
MAPK10 P53779 1/20 0.37
PTK2B Q14289 1/20 0.37
NCOA1 Q15788 1/20 0.37
NCOA3 Q9Y6Q9 1/20 0.37
FYN P06241 2/20 0.36
CYP1A1 P04798 2/20 0.36
CYP1B1 Q16678 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2E1 P05181 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13626931 0.95 ABL1 (0.42) ABL1ABCB1BCRFGFR1NPC1
SCHEMBL13626925 0.85 ABL1 (0.40) ABL1ABCB1BCRFGFR1NPC1
SCHEMBL1126107 0.84 FGFR1 (0.39) ABL1ABCB1BCRFGFR1NPC1
SCHEMBL1126222 0.81 FGFR1 (0.39) ABL1ABCB1BCRFGFR1NPC1
SCHEMBL1126072 0.81 CYP11B1 (0.39) ABL1ABCB1BCRFGFR1NPC1
SCHEMBL13626554 0.80 ABL1 (0.45) ABL1ABCB1BCRNPC1RAB9A
SCHEMBL13626928 0.80 ABL1 (0.40) ABL1ABCB1BCRFGFR1NPC1
SCHEMBL14212775 0.77 MAOB (0.37) ABL1ABCB1BCRFGFR1NPC1
SCHEMBL14212774 0.74 MAOB (0.37) ABL1ABCB1BCRFGFR1NPC1
SCHEMBL14212770 0.74 CYP11B1 (0.36) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009141386-A1 DERIVATIVES OF QUINOLINES AND QUINOXALINES AS PROTEIN TYROSINE KINASE INHIBITORS NOVARTIS AG (CH) 2009-11-26 WO disclosed